ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

Stronger Measures Needed To Reduce Conflict of Interest, IOM Report Says

May 1, 2009

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014

NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract

March 1, 1974